speb/financial-data huggingface dataset:
Stock screener scorecard for EME.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 17613398 (Nano Cap (< $50M))
Debt to equity: 0.0029
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FCP.LS (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 64799716 (Micro Cap ($50M-$300M))
P/E ratio: 2.4364775495997217
Debt to equity: -37.3354704279532
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for FMN.V (quarterly, report date 2026-04-30)
Altman Z-score: 3.175325287381282 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.757096663497249%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.677834072148778%
Rule of 40 score: 0
Market cap: 10596717 (Nano Cap (< $50M))
Debt to equity: 0.1042
Free cash flow (dilution adjusted): -414742.3357664233
Operating income: -126791.2408759124
Net income: -132163.50364963504
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for FOSECOIND.NS (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 2.7407621268480473%
Rule of 40 score: 2.7407621268480473
Market cap: 38236819456 (Large Cap ($10B-$200B))
P/E ratio: 0.40320669618554056
Operating income: 3516447.6473081815
Net income: 3583192.0305214073
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FVA.L (quarterly, report date 2026-02-28)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 73799448 (Micro Cap ($50M-$300M))
P/E ratio: 0.28153153153153154
Debt to equity: 0.28
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GANDHAR.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 57.68434936103184%
Rule of 40 score: 57.68434936103184
Market cap: 27647049728 (Large Cap ($10B-$200B))
P/E ratio: 0.06285582108118795
Debt to equity: 0.22510000000000002
Operating income: 28851144.635510072
Net income: 21720645.6377255
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GLPI (quarterly, report date 2026-03-31)
Altman Z-score: 1.0615304942503838 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.104676711062128%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.475124681020923%
Free cash flow margin: 35.86961439099016%
Revenue growth: 3.1825585766194715%
Rule of 40 score: 39.05217296760963
Market cap: 13164650496 (Large Cap ($10B-$200B))
P/E ratio: 13.5015479876161
Debt to equity: 1.6634
Free cash flow (dilution adjusted): 150647000
Operating income: 333349000
Net income: 239402000
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GRR.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 162027424 (Micro Cap ($50M-$300M))
P/E ratio: 4.697986577181208
Debt to equity: 0.0002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GRR.AX (annual, report date 2025-12-31)
Altman Z-score: 2.031250825704693 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.504825588478146%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.139298307846315%
Free cash flow margin: -4.586128817588636%
Revenue growth: -0.8575405562465237%
Rule of 40 score: -5.44366937383516
Market cap: 162027424 (Micro Cap ($50M-$300M))
P/E ratio: 4.697986577181208
Debt to equity: 0.0002
Free cash flow (dilution adjusted): -14708053.691275168
Operating income: 36965100.67114094
Net income: 31275167.7852349
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HAL.DE (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 24410322944 (Large Cap ($10B-$200B))
P/E ratio: 20.258387445887443
Debt to equity: 0.7419
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HBX.MC (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1828384256 (Small Cap ($300M-$2B))
P/E ratio: 7.683000604960678
Debt to equity: 1.5212999999999999
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HMI.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 14310.216777041942
Rule of 40 score: 0
Market cap: 5693252 (Nano Cap (< $50M))
Debt to equity: 1.9877
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HUM.AX (annual, report date 2025-06-30)
Altman Z-score: 0.4611364586689679 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.763863093658799%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 63.10909090909087%
Free cash flow margin: 24.12790697674419%
Revenue growth: 3.753936807883773%
Rule of 40 score: 27.88184378462796
Market cap: 227211504 (Micro Cap ($50M-$300M))
P/E ratio: 7.18954248366013
Debt to equity: 8.7883
Free cash flow (dilution adjusted): 103071895.4248366
Operating income: 226862745.0980392
Net income: 25882352.94117647
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HUM.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 227211504 (Micro Cap ($50M-$300M))
P/E ratio: 7.18954248366013
Debt to equity: 8.7883
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for IEP (quarterly, report date 2026-03-31)
Altman Z-score: 0.8907849839676295 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -85.29980657640233%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.0817417876241406%
Free cash flow margin: 11.44822006472492%
Revenue growth: 6.276870163370593%
Rule of 40 score: 17.725090228095514
Market cap: 5168068608 (Mid Cap ($2B-$10B))
Debt to equity: 2.9182
Free cash flow (dilution adjusted): 283000000
Operating income: -218000000
Net income: -450000000
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for IHD (quarterly, report date 2026-02-28)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 130003856 (Micro Cap ($50M-$300M))
P/E ratio: 2.795081967213115
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IHD (annual, report date 2026-02-28)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 31.87022668356449%
Capitalized R&D asset: 0
Revenue growth: 357.1575346462912%
Rule of 40 score: 357.1575346462912
Market cap: 130003856 (Micro Cap ($50M-$300M))
P/E ratio: 2.795081967213115
Debt to equity: 0
Net income: 43180610
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for INBS (quarterly, report date 2026-03-31)
Altman Z-score: -6.449149339577189 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -43.358796831673736%
Capitalized R&D asset: 1404230.48
ROCI (R&D adjusted): -23.009842977240353%
Rosenberg metric: 0.1448766837830125
Free cash flow margin: -409.30126451496136%
Revenue growth: 18.290896034006337%
Rule of 40 score: -391.01036848095504
Market cap: 4185730 (Nano Cap (< $50M))
Debt to equity: 0.2112
Free cash flow (dilution adjusted): -4341876
Operating income: -2941901
Net income: -2862712
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for IREN.SW (annual, report date 2025-12-31)
Altman Z-score: 2.1275948496754524 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.463740765143378%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.0750106146550493%
Free cash flow margin: 70.08557717607849%
Revenue growth: -40.458574884823285%
Rule of 40 score: 29.627002291255202
Market cap: 1951952896 (Small Cap ($300M-$2B))
P/E ratio: 15.065523068584
Debt to equity: 0.4305
Free cash flow (dilution adjusted): 70805063.29113923
Operating income: 67289873.41772151
Net income: 192453164.556962
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for IREN.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1951952896 (Small Cap ($300M-$2B))
P/E ratio: 15.065523068584
Debt to equity: 0.4305
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IVDA (quarterly, report date 2026-03-31)
Altman Z-score: -8.445676869501842 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.985943492604948%
Capitalized R&D asset: 79066
ROCI (R&D adjusted): -9.150997085645367%
Rosenberg metric: 7.805020644095789
Free cash flow margin: -62.85211762485494%
Revenue growth: 138.66992949354835%
Rule of 40 score: 75.81781186869341
Market cap: 2805754 (Nano Cap (< $50M))
Debt to equity: 0.0857
Free cash flow (dilution adjusted): -939120
Operating income: -565702
Net income: -532831
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for JFN.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1528707328 (Small Cap ($300M-$2B))
P/E ratio: 25.759493670886073
Debt to equity: 0.1543
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KIDZ (quarterly, report date 2026-03-31)
Altman Z-score: -1.9450255373915526 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 29700.74
ROCI (R&D adjusted): -8.834782068979482%
Rosenberg metric: -1.5106890773371249
Free cash flow margin: -158.69148186241085%
Revenue growth: -3.3365045734744068%
Rule of 40 score: -162.02798643588525
Market cap: 861317 (Nano Cap (< $50M))
Debt to equity: 1.7409000000000001
Free cash flow (dilution adjusted): -823923
Operating income: -894815
Net income: -4187534
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for KRPZ.L (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14826310 (Nano Cap (< $50M))
P/E ratio: 0.013513513513513514
Debt to equity: 1.0321
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LM1.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 22723498 (Nano Cap (< $50M))
Debt to equity: 0.0015
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NAC.AX (annual, report date 2025-06-30)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 21.408777300554192%
Capitalized R&D asset: 0
Free cash flow margin: -1.9440067886096681%
Rule of 40 score: -1.9440067886096681
Market cap: 26103000 (Nano Cap (< $50M))
P/E ratio: 0.885515496521189
Debt to equity: 0.4611
Free cash flow (dilution adjusted): -138771.8954248366
Net income: 4931756.862745098
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NAC.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 26103000 (Nano Cap (< $50M))
P/E ratio: 0.885515496521189
Debt to equity: 0.4611
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NHTC (quarterly, report date 2026-03-31)
Altman Z-score: -0.30145804679556104 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.5670553935860059%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.533810872935265%
Free cash flow margin: -9.811726734803658%
Revenue growth: -5.644097045985179%
Rule of 40 score: -15.455823780788837
Market cap: 15440128 (Nano Cap (< $50M))
Debt to equity: 0.18359999999999999
Free cash flow (dilution adjusted): -912000
Operating income: -474000
Net income: -154000
Long score: 2 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OMH.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 176239120 (Micro Cap ($50M-$300M))
Debt to equity: 0.511
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for OMH.AX (annual, report date 2025-12-31)
Altman Z-score: 1.5588865734937691 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.294493862874381%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.592702769096149%
Free cash flow margin: -3.680310542900025%
Revenue growth: 5.086101582587169%
Rule of 40 score: 1.405791039687144
Market cap: 176239120 (Micro Cap ($50M-$300M))
P/E ratio: 84.81346104725414
Debt to equity: 0.511
Free cash flow (dilution adjusted): -15716778.523489933
Operating income: -20932885.90604027
Net income: 1576510.067114094
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for PSEC (quarterly, report date 2026-03-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.9121913498217613%
Capitalized R&D asset: 0
Free cash flow margin: 293.42981403719256%
Revenue growth: 130.55910929774214%
Rule of 40 score: 423.9889233349347
Market cap: 1062136128 (Small Cap ($300M-$2B))
P/E ratio: 5.522004001354486
Debt to equity: 0.37920000000000004
Free cash flow (dilution adjusted): 195659000
Net income: 56479000
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RCH.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 131762040 (Micro Cap ($50M-$300M))
Debt to equity: 0.1699
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RGT (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 87.74519290021632%
Capitalized R&D asset: 0
Free cash flow margin: 3.015313600018023%
Revenue growth: 804.9970988688752%
Rule of 40 score: 808.0124124688932
Market cap: 95752008 (Micro Cap ($50M-$300M))
P/E ratio: 4.520689655172414
Debt to equity: 0
Free cash flow (dilution adjusted): 2674171
Net income: 87755875
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for RGT (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 95752008 (Micro Cap ($50M-$300M))
P/E ratio: 4.520689655172414
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for STS.V (quarterly, report date 2026-03-31)
Altman Z-score: -1.6598972519796544 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -29.19091041333238%
Capitalized R&D asset: 2676.561151079137
ROCI (R&D adjusted): -4.685240555516127%
Rule of 40 score: 0
Market cap: 21766022 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -714601.438848921
Operating income: -604658.273381295
Net income: -1132120.8633093527
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TIE.V (quarterly, report date 2026-03-31)
Altman Z-score: -8.50129379772036 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 18.63236769130922%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.57336716030444%
Revenue growth: -463.8066017774016%
Rule of 40 score: -463.8066017774016
Market cap: 5982426 (Nano Cap (< $50M))
P/E ratio: 0.5138746145940392
Debt to equity: 0
Free cash flow (dilution adjusted): 430215.8273381295
Operating income: 2264748.201438849
Net income: 2271942.4460431654
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TNE.L (quarterly, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 39815888 (Nano Cap (< $50M))
Debt to equity: -1.8119573348109155
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for UCL (quarterly, report date 2026-03-31)
Altman Z-score: 0.13203638695694464 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -13.82873431252227%
Capitalized R&D asset: 306944.8350034101
ROCI (R&D adjusted): -7.351942482372141%
Rosenberg metric: -7.591326530612244
Free cash flow margin: -51.533305652767055%
Revenue growth: -24.537767068938525%
Rule of 40 score: -76.07107272170558
Market cap: 34892500 (Nano Cap (< $50M))
P/E ratio: 13.999999999999998
Debt to equity: 0.4752
Free cash flow (dilution adjusted): -1108163.2653061224
Operating income: -341071.4285714286
Net income: -445535.7142857143
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for UGROCAP.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.32721967088268505 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.2176541679172854%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3249801282156524%
Revenue growth: 20.1772195062524%
Rule of 40 score: 20.1772195062524
Market cap: 14176694272 (Large Cap ($10B-$200B))
P/E ratio: 0.06508163141798545
Debt to equity: 3.7398000000000002
Operating income: -3285067.8253497244
Net income: 5416214.497668504
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for UGROCAP.NS (annual, report date 2026-03-31)
Altman Z-score: 0.5433201394759335 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.336537435166253%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.288828189671166%
Free cash flow margin: 11.846397707952612%
Revenue growth: 32.41701445490436%
Rule of 40 score: 44.26341216285697
Market cap: 14176694272 (Large Cap ($10B-$200B))
P/E ratio: 0.06508163141798545
Debt to equity: 3.7398000000000002
Free cash flow (dilution adjusted): 17674925.816023737
Operating income: 63570739.72022043
Net income: 18526303.518440016
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for XAIR (quarterly, report date 2026-03-31)
Altman Z-score: -12.562967666202798 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -194.08770555990603%
Capitalized R&D asset: 4711930
ROCI (R&D adjusted): -21.672765946930753%
Rosenberg metric: -0.08480856319473035
Free cash flow margin: -310.4352385946513%
Revenue growth: -13.081130355515041%
Rule of 40 score: -323.51636895016634
Market cap: 3717939 (Nano Cap (< $50M))
Debt to equity: 3.7655000000000003
Free cash flow (dilution adjusted): -5920000
Operating income: -7170000
Net income: -10282000
Long score: 0 | Short score: 13
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for XAIR (annual, report date 2026-03-31)
Altman Z-score: -14.439813787440611 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -599.5497259201253%
Capitalized R&D asset: 29574980
ROCI (R&D adjusted): -61.51803960764871%
Rosenberg metric: 0.1136026576496411
Free cash flow margin: -318.4138559708295%
Revenue growth: 107.2604588394062%
Rule of 40 score: -211.1533971314233
Market cap: 3717939 (Nano Cap (< $50M))
Debt to equity: 3.7655000000000003
Free cash flow (dilution adjusted): -24451000
Operating income: -29044000
Net income: -33249000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 1059.HK (annual, report date 2024-06-30)
Altman Z-score: -7.155779425432579 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.865499480086089%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.904513188195913%
Free cash flow margin: -3.4390822109417583%
Revenue growth: 18.74126206167063%
Rule of 40 score: 15.30217985072887
Market cap: 142512732.28 (Micro Cap ($50M-$300M))
P/E ratio: 24.897402564640114
Debt to equity: 0.037911396996590324
Free cash flow (dilution adjusted): -670550.576184379
Operating income: 1489500.6402048657
Net income: 732906.5300896288
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 278A.T (annual, report date 2026-01-31)
Altman Z-score: 7.90253545218818 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -64.59256153397529%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -21.813111388868016%
Free cash flow margin: -35.896361486518266%
Revenue growth: 8.48526065949434%
Rule of 40 score: -27.411100827023926
Market cap: 26068677499.999996 (Large Cap ($10B-$200B))
Debt to equity: 0.09005155112585901
Free cash flow (dilution adjusted): -11209023.243666753
Operating income: -7467948.550535388
Net income: -16309186.47166362
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for 3607.T (annual, report date 2025-08-31)
Altman Z-score: 1.598935182052971 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.535011595907657%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.666942411944878%
Free cash flow margin: 2.245998149825574%
Revenue growth: 1.4828552439109628%
Rule of 40 score: 3.7288533937365367
Market cap: 3243099169.2 (Mid Cap ($2B-$10B))
P/E ratio: 10.383566001344732
Debt to equity: 1.4497119491332766
Free cash flow (dilution adjusted): 2079549.0156005179
Operating income: 2739519.040806595
Net income: 2127733.496832209
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4576.T (annual, report date 2025-12-31)
Altman Z-score: 4.334360217384293 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -40.982168650486294%
Capitalized R&D asset: 12290681.581369381
ROCI (R&D adjusted): -24.964555935105878%
Rosenberg metric: -0.054601856886181785
Free cash flow margin: -138.3927557917548%
Revenue growth: -17.499178597594277%
Rule of 40 score: -155.89193438934907
Market cap: 5437505069.465803 (Mid Cap ($2B-$10B))
Debt to equity: 0.42159491559783735
Free cash flow (dilution adjusted): -3429691.196215076
Operating income: -3963109.7755897962
Net income: -4041218.5921616266
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for 7800.T (annual, report date 2025-09-30)
Altman Z-score: 4.807549173036265 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.890277527447875%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.259756032761748%
Free cash flow margin: 5.6559421547001%
Revenue growth: -1.2349707682861866%
Rule of 40 score: 4.420971386413914
Market cap: 1963322210 (Small Cap ($300M-$2B))
P/E ratio: 10.09404590160563
Debt to equity: 0.23380134229190833
Free cash flow (dilution adjusted): 3365477.792732167
Operating income: 1819125.1682368775
Net income: 1308903.0955585465
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 8125.HK (annual, report date 2025-03-31)
Altman Z-score: 2.1462824832455123 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.563268460619682%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -38.95112187573586%
Free cash flow margin: -21.340926080112794%
Revenue growth: 89.03516351387411%
Rule of 40 score: 67.69423743376132
Market cap: 68617696 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -4513496.143958868
Operating income: -2976606.683804627
Net income: -2786375.3213367607
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 8370.HK (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 785628234.5369427 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9173.T (annual, report date 2025-12-31)
Altman Z-score: 1.395565617352521 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 25.703835422359077%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.3524323125586424%
Free cash flow margin: 2.1847967056512494%
Revenue growth: -1.8019599632372214%
Rule of 40 score: 0.382836742414028
Market cap: 7106790913.770911 (Mid Cap ($2B-$10B))
P/E ratio: 16.554948143473244
Debt to equity: 1.4824717634610496
Free cash flow (dilution adjusted): 1995869.8292948022
Operating income: 3347938.111373953
Net income: 2744613.515759862
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ABN.AS (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.248388547444163%
Capitalized R&D asset: 0
Free cash flow margin: 21.10627576729272%
Revenue growth: 10.859077443927202%
Rule of 40 score: 31.96535321121992
Market cap: 23453849820.14 (Large Cap ($10B-$200B))
P/E ratio: 10.414675763827708
Debt to equity: 2.9369152830677097
Free cash flow (dilution adjusted): 2168235294.117647
Net income: 2649411764.7058825
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ACVA (annual, report date 2025-12-31)
Altman Z-score: 1.3345995923849148 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -37.96070868988791%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.50580809372377%
Free cash flow margin: -3.0651416655476655%
Revenue growth: 19.21821343595603%
Rule of 40 score: 16.153071770408367
Market cap: 1400170849.8799999 (Small Cap ($300M-$2B))
Debt to equity: 0.44218644907990307
Free cash flow (dilution adjusted): -23283000
Operating income: -63191000
Net income: -66141000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for ARES (annual, report date 2025-12-31)
Altman Z-score: 1.3391683177919778 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -97.28499761293004%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.221907062768753%
Free cash flow margin: 43.813976372681374%
Revenue growth: 44.19041897085061%
Rule of 40 score: 88.00439534353198
Market cap: 35051626823.270004 (Large Cap ($10B-$200B))
P/E ratio: 32.20597158588443
Debt to equity: 1.6392479471172043
Free cash flow (dilution adjusted): 2454232000
Operating income: 892716000
Net income: 1088358000
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AUC (annual, report date 2025-07-31)
Altman Z-score: 46.605504643716394 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -47.423064684288%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.716833230282067%
Free cash flow margin: -204.783%
Revenue growth: 93.54838709677419%
Rule of 40 score: -111.2346129032258
Market cap: 65180517.36 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -2457396
Operating income: -842349
Net income: -4597998
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for BKU (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.962865299012966%
Capitalized R&D asset: 0
Free cash flow margin: 30.931039434916517%
Revenue growth: 7.8741214164695625%
Rule of 40 score: 38.80516085138608
Market cap: 3195088147.44 (Mid Cap ($2B-$10B))
P/E ratio: 11.906288163128417
Debt to equity: 0.6138981586722767
Free cash flow (dilution adjusted): 338144000
Net income: 268353000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for D2G.DE (annual, report date 2025-12-31)
Altman Z-score: 1.4002661911648597 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -29.600194399576896%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.381030275223257%
Free cash flow margin: -48.79256673898689%
Revenue growth: 21.881876074555755%
Rule of 40 score: -26.910690664431137
Market cap: 160427904251.29413 (Large Cap ($10B-$200B))
P/E ratio: 50.688121406412044
Debt to equity: 0.7241592308363715
Free cash flow (dilution adjusted): -4879716981.132075
Operating income: 2071855345.9119496
Net income: 497641509.4339622
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for FCP.LS (annual, report date 2025-06-30)
Altman Z-score: -0.6352087595966339 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -32.90559787406376%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.074156818637041%
Free cash flow margin: -93.98190754715696%
Revenue growth: -7.161575350995561%
Rule of 40 score: -101.14348289815253
Market cap: 23624895 (Nano Cap (< $50M))
P/E ratio: 0.5763856494583781
Debt to equity: -26.60996366418046
Free cash flow (dilution adjusted): -162191764.70588237
Operating income: -34643529.4117647
Net income: 48221176.47058824
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for FMN.V (annual, report date 2025-07-31)
Altman Z-score: -2.6067695579924215 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.01158755719121%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -11.915479321406897%
Rule of 40 score: 0
Market cap: 4325190.600000001 (Nano Cap (< $50M))
Debt to equity: 0.2605357389067037
Free cash flow (dilution adjusted): -452739.13043478265
Operating income: -478014.4927536232
Net income: -567046.3768115942
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for GLPI (annual, report date 2025-12-31)
Altman Z-score: 1.3969266084748233 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 29.849128450492607%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.599037257009138%
Free cash flow margin: 50.40238231398989%
Revenue growth: 4.126941012545493%
Rule of 40 score: 54.52932332653538
Market cap: 12240847968.02 (Large Cap ($10B-$200B))
P/E ratio: 14.394968657856237
Debt to equity: 1.4990098357513388
Free cash flow (dilution adjusted): 803793000
Operating income: 1207628000
Net income: 850356000
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HBX.MC (annual, report date 2025-09-30)
Altman Z-score: 0.28705159554584864 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.243558580456975%
Free cash flow margin: 17.994858611825194%
Revenue growth: 6.125641118911651%
Rule of 40 score: 24.120499730736846
Market cap: 1499997725.0110588 (Small Cap ($300M-$2B))
Debt to equity: 1.5474083438685207
Free cash flow (dilution adjusted): 189189189.1891892
Operating income: 201351351.35135135
Net income: -93243243.24324325
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for IEP (annual, report date 2025-12-31)
Altman Z-score: 1.4479968029178836 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.379125095932464%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.9665367121507472%
Free cash flow margin: -7.036040882194729%
Revenue growth: -6.111111111111111%
Rule of 40 score: -13.14715199330584
Market cap: 4469136177.45 (Mid Cap ($2B-$10B))
Debt to equity: 1.9311150029188557
Free cash flow (dilution adjusted): -654000000
Operating income: -119000000
Net income: -293000000
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for INBS (annual, report date 2025-06-30)
Altman Z-score: -10.047372888410116 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3685412.94
ROCI (R&D adjusted): -145.10506006077574%
Rosenberg metric: -0.10680269995447501
Free cash flow margin: -332.4189885642476%
Revenue growth: -1.9040221660843097%
Rule of 40 score: -334.32301073033193
Market cap: 41139751.199999996 (Nano Cap (< $50M))
Debt to equity: 0.1001501870763772
Free cash flow (dilution adjusted): -10147196
Operating income: -10424545
Net income: -10568733
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for IVDA (annual, report date 2025-12-31)
Altman Z-score: -8.655597143501783 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -66.45786965961904%
Capitalized R&D asset: 677291.46
ROCI (R&D adjusted): -59.951631075095335%
Rosenberg metric: -0.07915783679647723
Free cash flow margin: -45.51816256312127%
Revenue growth: -12.296485472721418%
Rule of 40 score: -57.814648035842694
Market cap: 9738982.68 (Nano Cap (< $50M))
Debt to equity: 0.14843165831269423
Free cash flow (dilution adjusted): -2403501
Operating income: -3226896
Net income: -3198112
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for KIDZ (annual, report date 2025-12-31)
Altman Z-score: 7.7103824111540655 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 89583.07999999999
ROCI (R&D adjusted): -26.854059069279373%
Rosenberg metric: -3.602690171702247
Free cash flow margin: -162.76826338714022%
Revenue growth: -8.411760352856293%
Rule of 40 score: -171.18002373999653
Market cap: 181745832 (Micro Cap ($50M-$300M))
Debt to equity: 2.5001879792809767
Free cash flow (dilution adjusted): -5479465
Operating income: -3591672
Net income: -7044865
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for KRPZ.L (annual, report date 2022-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -203.54703773262762%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.712184997818421%
Rule of 40 score: 0
Market cap: 0 (Nano Cap (< $50M))
Debt to equity: 1.1875046292867193
Free cash flow (dilution adjusted): -46386746.987951815
Operating income: -6857831.325301205
Net income: -80287951.80722892
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for LUMN (annual, report date 2025-12-31)
Altman Z-score: -0.20126374948612719 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.6143162393162394%
Free cash flow margin: 2.6044186421544913%
Revenue growth: -5.386023802258163%
Rule of 40 score: -2.7816051601036715
Market cap: 8005517013.9 (Mid Cap ($2B-$10B))
Debt to equity: -15.852282900626678
Free cash flow (dilution adjusted): 323000000
Operating income: -184000000
Net income: -1739000000
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for NHTC (annual, report date 2025-12-31)
Altman Z-score: 1.1996158242550892 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.5895684835033506%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.30800323362975%
Free cash flow margin: -15.455021572686237%
Revenue growth: -7.339449541284404%
Rule of 40 score: -22.79447111397064
Market cap: 24961537.68 (Nano Cap (< $50M))
Debt to equity: 0.08536429211660762
Free cash flow (dilution adjusted): -6197000
Operating income: -1808000
Net income: -882000
Long score: 2 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for PSEC (annual, report date 2025-06-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.722979203498962%
Capitalized R&D asset: 0
Revenue growth: -226.80610260756842%
Rule of 40 score: -226.80610260756842
Market cap: 1312640050.8600001 (Small Cap ($300M-$2B))
Debt to equity: 0.6987187379967424
Free cash flow (dilution adjusted): 523171000
Net income: -469924000
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for STS.V (annual, report date 2025-12-31)
Altman Z-score: -2.197084432996859 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.46112179673751%
Capitalized R&D asset: 66468.13986013987
ROCI (R&D adjusted): -29.73938710171971%
Rosenberg metric: 0.045717540521745655
Rule of 40 score: 0
Market cap: 19659632.16 (Nano Cap (< $50M))
Debt to equity: 0.0324506235300383
Free cash flow (dilution adjusted): -4159818.248175182
Operating income: -4047980.2919708025
Net income: -1009239.4160583941
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TIE.V (annual, report date 2025-09-30)
Altman Z-score: -10.33851887823218 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -36.79499754781756%
Capitalized R&D asset: 12903.703703703704
ROCI (R&D adjusted): -36.888836564576835%
Rosenberg metric: -5.971499723298291
Rule of 40 score: 0
Market cap: 6420164.960000001 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -305035.9712230216
Operating income: -4327338.129496403
Net income: -4317985.611510792
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for TNE.L (annual, report date 2024-12-31)
Altman Z-score: -8.937643541981373 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1712.1816399577615%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1712.1264917020749%
Rule of 40 score: 0
Market cap: 95558.13 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -362905.025
Operating income: -757418.65
Net income: -757417.1499999999
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for UCL (annual, report date 2025-12-31)
Altman Z-score: 2.354969456756489 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 29.72399901049581%
Capitalized R&D asset: 1433632.2712065466
ROCI (R&D adjusted): 2.3125895409351584%
Rosenberg metric: -0.28843577536828846
Free cash flow margin: 1.373865854706626%
Revenue growth: -11.344334001991546%
Rule of 40 score: -9.97046814728492
Market cap: 330271279.55840003 (Small Cap ($300M-$2B))
P/E ratio: 52.41569267709887
Debt to equity: 0.31248264371008055
Free cash flow (dilution adjusted): 143830.33419023134
Operating income: 250128.53470437016
Net income: 809897.1722365038
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for 0499.HK (annual, report date 2025-12-31)
Altman Z-score: -0.5345028987353145 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -16.46028179807374%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.762663810702242%
Free cash flow margin: -54.23934680657243%
Revenue growth: -33.317978982398515%
Rule of 40 score: -87.55732578897094
Market cap: 188726576 (Micro Cap ($50M-$300M))
Debt to equity: 1.3104
Free cash flow (dilution adjusted): -2066323.907455013
Operating income: -1395372.7506426736
Net income: -5605269.922879177
Long score: 0 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 0499.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 188726576 (Micro Cap ($50M-$300M))
Debt to equity: 1.3104
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 0587.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 511494208 (Small Cap ($300M-$2B))
Debt to equity: 1.4001
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0587.HK (annual, report date 2025-12-31)
Altman Z-score: 0.3294972395541192 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.064177190837176%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.2099711699955025%
Free cash flow margin: 19.30007346149977%
Revenue growth: 1.4003766641008193%
Rule of 40 score: 20.70045012560059
Market cap: 511494208 (Small Cap ($300M-$2B))
Debt to equity: 1.4001
Free cash flow (dilution adjusted): 45226000
Operating income: -12599142.857142856
Net income: -32632428.57142857
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 0912.HK (annual, report date 2026-03-31)
Altman Z-score: 3.107140194598743 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.687148058766248%
Capitalized R&D asset: 2849107.1428571427
ROCI (R&D adjusted): 10.400904294818119%
Free cash flow margin: 0.9056172372590904%
Revenue growth: 24.575946824828566%
Rule of 40 score: 25.481564062087656
Market cap: 316116928 (Small Cap ($300M-$2B))
P/E ratio: 0.9293002915451894
Debt to equity: 0.0083
Free cash flow (dilution adjusted): 2012755.1020408166
Operating income: 9492729.591836736
Net income: 5159948.979591837
Long score: 8 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 0912.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 316116928 (Small Cap ($300M-$2B))
P/E ratio: 0.9293002915451894
Debt to equity: 0.0083
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2139.T (annual, report date 2026-03-31)
Altman Z-score: 3.800138123258588 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.723549047194652%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.090864423624524%
Free cash flow margin: 3.235514849348278%
Revenue growth: 0.3827029190051561%
Rule of 40 score: 3.6182177683534342
Market cap: 3604012800 (Mid Cap ($2B-$10B))
P/E ratio: 0.11237294395949979
Debt to equity: 0.5706
Free cash flow (dilution adjusted): 2460122.6226226226
Operating income: 2420289.039039039
Net income: 1283464.7147147148
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 2139.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3604012800 (Mid Cap ($2B-$10B))
P/E ratio: 0.11237294395949979
Debt to equity: 0.5706
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2147.HK (quarterly, report date 2024-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 35616000 (Nano Cap (< $50M))
Debt to equity: 0.6157
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2147.HK (annual, report date 2024-12-31)
Altman Z-score: 3.14014136846824 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.7505216740816572%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.285349254079364%
Free cash flow margin: -9.873903336373072%
Revenue growth: -2.602739726027392%
Rule of 40 score: -12.476643062400465
Market cap: 35616000 (Nano Cap (< $50M))
P/E ratio: 0.7677699804967025
Debt to equity: 0.6157
Free cash flow (dilution adjusted): -6021917.808219179
Operating income: 11440547.94520548
Net income: 9248904.109589042
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2280.HK (quarterly, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 269845824 (Micro Cap ($50M-$300M))
Debt to equity: 0.9499
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2299.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12029393920 (Large Cap ($10B-$200B))
P/E ratio: 1.7994858611825195
Debt to equity: 0.1821
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2565.HK (annual, report date 2025-12-31)
Altman Z-score: 6.514374590226254 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -46.49926105185139%
Capitalized R&D asset: 26944026.118226033
ROCI (R&D adjusted): -43.36912562512531%
Rosenberg metric: 0
Rule of 40 score: 0
Market cap: 2499074816 (Mid Cap ($2B-$10B))
Debt to equity: 0.2087
Free cash flow (dilution adjusted): -33998428.57142857
Operating income: -29415142.85714286
Net income: -29766000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 2565.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2499074816 (Mid Cap ($2B-$10B))
Debt to equity: 0.2087
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2608.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 25508114 (Nano Cap (< $50M))
Debt to equity: -2.660298246925763
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2608.HK (annual, report date 2025-12-31)
Altman Z-score: -0.9728073914854385 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: 2.6549220090880548%
Revenue growth: -9.828701461905558%
Rule of 40 score: -7.173779452817503
Market cap: 25508114 (Nano Cap (< $50M))
Debt to equity: -2.660298246925763
Free cash flow (dilution adjusted): 6620571.428571428
Operating income: -16376571.42857143
Net income: -512153571.4285714
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 3667.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1276600576 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3686.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 568820032 (Small Cap ($300M-$2B))
P/E ratio: 0.261086118251928
Debt to equity: 0.051699999999999996
Long score: 2 | Short score: 2
Recommendation: Neutral